Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | LTC4S | Q16873 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29349638 | 0.82 | SIGMAR1 (0.46) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL13854486 | 0.82 | SIGMAR1 (0.46) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL23047 | 0.82 | SIGMAR1 (0.46) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL75887 | 0.82 | SIGMAR1 (0.46) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL6123830 | 0.82 | SIGMAR1 (0.46) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL3463498 | 0.82 | SIGMAR1 (0.46) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL17690821 | 0.82 | SIGMAR1 (0.46) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL15807471 | 0.82 | SIGMAR1 (0.46) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL76513 | 0.82 | SIGMAR1 (0.46) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL6481487 | 0.82 | SIGMAR1 (0.46) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8481174-B2 | Organic light-emitting compound of CIS-diarylethene derivatives, organic electroluminescent device using the same, and method of manufacturing the device | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-07-09 | — | — | US | disclosed |
| US-8481174-B2 | Organic light-emitting compound of CIS-diarylethene derivatives, organic electroluminescent device using the same, and method of manufacturing the device | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-07-09 | — | — | US | disclosed |
| US-20070276160-A1 | Organic light-emitting compound of CIS-diarylethene derivatives, organic electroluminescent device using the same, and method of manufacturing the device | SAMSUNG DISPLAY CO., LTD. (KR) | 2007-11-29 | — | — | US | disclosed |
| US-20070276160-A1 | Organic light-emitting compound of CIS-diarylethene derivatives, organic electroluminescent device using the same, and method of manufacturing the device | SAMSUNG DISPLAY CO., LTD. (KR) | 2007-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070276160-A1 | Organic light-emitting compound of CIS-diarylethene derivatives, organic electroluminescent device using the same, and method of manufacturing the device | LEF1, EML4, LAS1L | SIGMAR1 4181/4885SLC6A3 3075/4885TNK2 3485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.